Hongchang International Swings to Profit on Doubled Revenue

TL;DR

**HCIL's Q2 profit surge and revenue doubling is a strong buy signal, but watch those related party dealings closely.**

AI Summary

Hongchang International Co., Ltd (HCIL) reported a significant turnaround for the three months ended June 30, 2025, achieving a net income of $499,942 compared to a net loss of $21,680 in the prior-year period. Revenue more than doubled, reaching $3,844,148, up from $1,981,898 in Q2 2024, driven by its food trade and biotechnology businesses. Gross profit surged to $613,712 from $98,715 year-over-year. Operating income also saw a substantial improvement, moving from a loss of $24,014 in Q2 2024 to an income of $537,435 in Q2 2025. The company's total assets slightly decreased to $58,937,106 as of June 30, 2025, from $59,538,093 as of March 31, 2025, primarily due to a reduction in cash and cash equivalents from $493,201 to $50,043. Accounts receivable also decreased from $2,278,878 to $1,391,532. Strategic changes include the acquisition of a 51% equity interest in Pucheng Green Health Food on January 1, 2025, expanding its livestock slaughtering business, and the establishment of Hongfu Food with a 51% stake for hog processing and pork product trading on May 8, 2024. Risks include significant related party transactions and the inherent volatility of foreign currency translation, which generated a positive adjustment of $539,252 in Q2 2025.

Why It Matters

This turnaround signals a potential inflection point for HCIL, moving from a loss-making entity to profitability, which could attract new investor interest. The substantial revenue growth and improved gross margins suggest effective business expansion, particularly in the food trade and biotechnology sectors, and the strategic acquisitions of Hongfu Food and Pucheng Green Health Food indicate a clear growth strategy in meat processing. For employees, this could mean greater job security and potential for growth. Customers may benefit from expanded product offerings and supply chain efficiencies. However, the significant related party transactions and reliance on a single controlling family (Mr. Zengqiang Lin and Ms. Zhenzhu Lin) introduce governance risks that could deter institutional investors and impact market perception, especially given the company's relatively small size and recent reverse merger history.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant related party transactions, including 'Amounts due to related parties - current portion' of $2,986,876 and 'Amounts due to related parties' of $3,558,083 as of June 30, 2025. Additionally, the company's cash and cash equivalents dropped sharply from $493,201 to $50,043, indicating potential liquidity concerns despite the net income. The company also operates in the PRC, which carries inherent geopolitical and regulatory risks.

Analyst Insight

Investors should closely monitor HCIL's cash flow and the nature of its related party transactions for any signs of financial strain or governance issues. While the revenue and profit growth are positive, further due diligence on the sustainability of these gains and the company's capital structure is warranted before making a significant investment.

Financial Highlights

debt To Equity

0.40

revenue

$3,844,148

operating Margin

14.0%

total Assets

$58,937,106

total Debt

$11,401,515

net Income

$499,942

eps

N/A

gross Margin

16.0%

cash Position

$50,043

revenue Growth

+93.9%

Revenue Breakdown

Key Numbers

• $3.84M — Revenue (Increased from $1.98M in Q2 2024, a 93.9% increase)
• $499,942 — Net Income (Swung from a net loss of $21,680 in Q2 2024)
• $613,712 — Gross Profit (Increased from $98,715 in Q2 2024, a 521.7% increase)
• $537,435 — Operating Income (Swung from an operating loss of $24,014 in Q2 2024)
• $50,043 — Cash and Cash Equivalents (Decreased significantly from $493,201 as of March 31, 2025)
• $2,986,876 — Current Amounts Due to Related Parties (Significant current liability as of June 30, 2025)
• $3,558,083 — Non-Current Amounts Due to Related Parties (Significant non-current liability as of June 30, 2025)
• 518,831,367 — Common Stock Shares Outstanding (Consistent as of June 30, 2025 and March 31, 2025)
• $539,252 — Foreign Currency Translation Difference (Positive impact on comprehensive income in Q2 2025)
• $1,391,532 — Accounts Receivable (Decreased from $2,278,878 as of March 31, 2025)

Key Players & Entities

• Hongchang International Co., Ltd (company) — registrant
• Hongchang BVI (company) — wholly owned subsidiary after merger
• Mr. Zengqiang Lin (person) — director and controlling stockholder
• Ms. Zhenzhu Lin (person) — controlling stockholder
• Pucheng Green Health Food Co., Ltd. (company) — 51% acquired subsidiary
• Hongfu Food (Fujian) Co. Ltd. (company) — 51% owned joint venture
• SEC (regulator) — U.S. Securities and Exchange Commission
• Fujian Xindefu Agricultural Products Co., Ltd. (company) — shareholder in Hongfu Food
• Hongchang Food (company) — subsidiary engaged in food trade and biotechnology
• Long Yuan (person) — purchaser of Hongchang Agricultural

FAQ

Risk Factors

• Related Party Transactions [high — financial]: The company has significant current liabilities of $2,986,876 and non-current liabilities of $3,558,083 due to related parties as of June 30, 2025. These transactions, while not explicitly detailed, represent a concentration of financial exposure and potential conflicts of interest.
• Foreign Currency Volatility [medium — financial]: The company is exposed to foreign currency translation risks. In Q2 2025, a positive adjustment of $539,252 was recorded due to foreign currency translation differences, indicating potential for significant fluctuations in reported earnings.
• Cash and Inventory Management [medium — operational]: Cash and cash equivalents decreased substantially from $493,201 to $50,043 between March 31, 2025, and June 30, 2025. Inventories also decreased from $36,206 to $29,364, suggesting potential cash flow constraints or strategic inventory reduction.
• Accounts Receivable Reduction [low — operational]: Accounts receivable decreased from $2,278,878 to $1,391,532, which could indicate improved collection efforts or a slowdown in sales on credit. Further analysis is needed to determine the underlying cause.
• Dependence on Acquired Businesses [medium — operational]: The company's growth is significantly tied to its recent acquisitions, Pucheng Green Health Food and Hongfu Food. The success and integration of these businesses are critical for continued revenue growth and profitability.

Industry Context

Hongchang International operates within the food trade and biotechnology sectors, which are experiencing dynamic growth, particularly in processed foods and health-related products. The company's strategic acquisitions in livestock slaughtering and hog processing position it to capitalize on demand for meat products. However, the industry is subject to supply chain volatility, food safety regulations, and fluctuating commodity prices.

Regulatory Implications

The company's operations, especially in food processing and biotechnology, are subject to stringent food safety and environmental regulations in its operating jurisdictions. Compliance with these regulations is crucial to avoid penalties and maintain consumer trust. The significant related party transactions may also attract scrutiny from regulatory bodies.

What Investors Should Do

1. Monitor related party transactions
2. Analyze cash flow trends
3. Evaluate integration of acquisitions
4. Assess foreign currency exposure management

Key Dates

• 2025-01-01: Acquisition of 51% equity interest in Pucheng Green Health Food — Expanded the company's livestock slaughtering business, contributing to the significant revenue increase in Q2 2025.
• 2024-05-08: Establishment of Hongfu Food with a 51% stake — Created a new entity for hog processing and pork product trading, supporting the growth in the food trade segment.
• 2025-06-30: End of Q2 2025 — Reported a strong financial turnaround with net income of $499,942 and revenue of $3,844,148, a significant improvement from Q2 2024.
• 2025-03-31: End of Q1 2025 — Cash and cash equivalents stood at $493,201, and accounts receivable were $2,278,878, providing a baseline for comparison with Q2 2025 figures.

Glossary

Accumulated other comprehensive income (loss)

Includes unrealized gains and losses that are not reported in net income but affect total equity. For HCIL, this includes foreign currency translation adjustments. (Shows a positive swing from a loss of $131,400 in Q1 2025 to a gain of $406,053 in Q2 2025, largely due to a $539,252 foreign currency translation difference.)

Non-controlling interests

Represents the portion of equity in a subsidiary that is not owned by the parent company. It is reported separately within total equity. (Increased from $815,055 to $1,007,107, indicating a growing stake or improved performance in subsidiaries not wholly owned by HCIL.)

Equity-method investments

Investments in other companies where the investor has significant influence but not control. The investment is adjusted for the investor's share of the investee's net income or loss. (Decreased from $527,684 to $0, suggesting that the investment was either sold, written off, or consolidated into the company's operations.)

Construction-in-progress

Assets that are currently under construction or development and are not yet ready for their intended use. These are capitalized costs. (Increased from $16,832,470 to $17,458,476, indicating ongoing investment in long-term assets, likely related to the expansion of its food processing and biotechnology operations.)

Statutory reserves

Reserves set aside by law or company articles of association, often from profits, for specific purposes. (Remained stable at $1,197, indicating no significant changes in profit distribution or legal requirements impacting these reserves.)

Year-Over-Year Comparison

Hongchang International Co., Ltd. has demonstrated a remarkable turnaround in Q2 2025 compared to Q2 2024. Revenue more than doubled, increasing by 93.9% to $3.84 million, driven by strategic acquisitions in the food sector. Gross profit surged by 521.7% to $613,712, and operating income swung from a loss of $24,014 to a profit of $537,435. Net income also turned positive, reaching $499,942 from a net loss of $21,680. While overall assets slightly decreased due to a significant reduction in cash and receivables, the operational performance shows substantial improvement. New risks related to the integration of acquired businesses and continued monitoring of related party transactions are now more prominent.

Key Financial Figures

• $ — functional currency of the Company is US$, and the functional currency of the Com

Filing Documents

• ea0252560-10q_hongchang.htm (10-Q) — 745KB
• ea025256001ex31-1_hongchang.htm (EX-31.1) — 10KB
• ea025256001ex31-2_hongchang.htm (EX-31.2) — 10KB
• ea025256001ex32-1_hongchang.htm (EX-32.1) — 6KB
• ea025256001ex32-2_hongchang.htm (EX-32.2) — 5KB
• 0001213900-25-076627.txt ( ) — 5927KB
• hcil-20250630.xsd (EX-101.SCH) — 70KB
• hcil-20250630_cal.xml (EX-101.CAL) — 57KB
• hcil-20250630_def.xml (EX-101.DEF) — 284KB
• hcil-20250630_lab.xml (EX-101.LAB) — 517KB
• hcil-20250630_pre.xml (EX-101.PRE) — 306KB
• ea0252560-10q_hongchang_htm.xml (XML) — 702KB

. FINANCIAL INFORMATION

Part I . FINANCIAL INFORMATION 1 Item 1.

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets (Unaudited) 1 Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) 2 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) 3 Condensed Consolidated Statement of Cash Flows (Unaudited) 4 Notes to Condensed Consolidated Financial Statements (Unaudited) 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 32 Item 4.

Controls and Procedures

Controls and Procedures 32

. OTHER INFORMATION

Part II . OTHER INFORMATION 33 Item 1.

Legal Proceedings

Legal Proceedings 33 Item 1A.

Risk Factors

Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 33 Item 3. Defaults Upon Senior Securities 33 Item 4. Mine Safety Disclosures 33 Item 5. Other Information 33 Item 6. Exhibits 34 i

FORWARD LOOKING STATEMENTS

FORWARD LOOKING STATEMENTS This quarterly report on Form 10-Q (this "Report"), financial statements, and notes to financial statements contain forward-looking statements that discuss, among other things, future expectations and projections regarding future developments, operations, and financial conditions. Forward-looking statements may appear throughout this Report and other documents we file with the U.S. Securities and Exchange Commission (the "SEC"), including without limitation, the following section: Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Report.

Forward-looking statements generally can be identified

Forward-looking statements generally can be identified by words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "will be," "will continue," "may," "could," "will likely result," and similar expressions. These forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those reflected in the forward-looking statements. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. ii

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Hongchang International Co., Ltd Condensed Consolidated Balance Sheets As of June 30, 2025 March 31, 2025 (unaudited) US$ US$ ASSETS: Current assets: Cash and cash equivalents 50,043 493,201 Restricted cash 220,500 217,700 Accounts receivable 1,391,532 2,278,878 Amount due from a related party - - Other receivable 752,314 74,693 Inventories, net 29,364 36,206 Advance to suppliers 119,961 175,389 Other current assets 731,612 757,833 Total current assets 3,295,326 4,033,900 Non-current assets: Property and equipment, net 27,321,360 27,139,534 Construction-in-progress 17,458,476 16,832,470 Intangible assets, net - - Land use rights, net 4,026,608 3,998,567 Equity-method investments - 527,684 Other non-current assets 6,835,336 7,005,938 Total non-current assets 55,641,780 55,504,193 Total assets 58,937,106 59,538,093 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Long-term loans -current portion 421,516 378,026 Accounts payable 894,801 2,263,805 Accounts payable-construction in progress 19,650 13,639 Amounts due to related parties -current portion 2,986,876 2,950,075 Advances from customers 259 256 Accrued expenses and other liabilities 461,988 841,789 Total current liabilities 4,785,090 6,447,590 Non-current liabilities Deferred subsidies 1,951,745 1,935,462 Long term loans 6,522,479 6,556,390 Amounts due to related parties 3,558,083 3,513,737 Deferred Tax Liability 3,275 7,675 Total non-current liabilities 12,035,582 12,013,264 Total liabilities 16,820,672 18,460,854 Commitments and contingencies - - Stockholders' equity: Common stock (US$ 0.001 par value; 2,000,000,000 shares authorized; 518,831,367 and 518,831,367 issued and outstanding as of June 30, 2025 and March 31, 2025) 518,831 518,831 Additional paid-in capital 39,905,228 39,905,228 Statutory reserves 1,197 1,1

View Full Filing

View this 10-Q filing on SEC EDGAR